Status:
COMPLETED
Wrist Arthroscopy Study
Lead Sponsor:
NYU Langone Health
Conditions:
Wrist Arthropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the diagnostic efficacy of Arthrex NanoScope compared to conventional arthroscopic instruments. Patients with wrist pathology who are indicated for an arthrosc...
Eligibility Criteria
Inclusion
- Age \> 18 years.
- Wrist pathology based on clinical examination/imaging studies undergoing wrist arthroscopy for further evaluation/treatment.
- Willingness to participate in the study
Exclusion
- 1\. Age \< 18 years.
Key Trial Info
Start Date :
October 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04457362
Start Date
October 10 2020
End Date
March 22 2023
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016